News of financial entanglements among biomedical companies and
researchers has increasingly called into question the worth and
integrity of medical studies, nearly three-fifths of which are
funded by industry. This volume assesses the ethical, quantitative,
and qualitative questions posed by the current financing of
biomedical research.
The ten essays collected here reflect the wide range of opinions
about perceived financial conflicts of interest in medical studies.
The opening section provides an overview of the issue, describing
the origins of, and concerns raised by, dubious financial
arrangements; explaining how certain common situations intensify
problematic funding structures; weighing the risks and benefits of
commercialized research funding; and detailing the nature, extent,
and consequences of the present relationship among academe,
government, and industry in the health sciences. The second section
compares how the idea of conflicts of interest differs in
biomedical research, legal work, and journalism. It includes a
challenging look at the term itself and an argument for managed
financial incentives. The final section describes and analyzes the
existing regulatory regime, poses questions and directions for
future self and external regulation, and provides perspectives from
a third-party research company.
This considered, balanced discussion will interest scholars of
bioethics, public health, and health policy.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!